tylvalosin and Viremia

tylvalosin has been researched along with Viremia* in 1 studies

Other Studies

1 other study(ies) available for tylvalosin and Viremia

ArticleYear
Effects of a water-soluble formulation of tylvalosin on disease caused by porcine reproductive and respiratory syndrome virus alone in sows or in combination with Mycoplasma hyopneumoniae in piglets.
    BMC veterinary research, 2023, Feb-01, Volume: 19, Issue:1

    The effect of a water-soluble formulation of tylvalosin (Aivlosin® 625 mg/g granules) on disease caused by porcine reproductive and respiratory syndrome virus (PRRSV) and Mycoplasma hyopneumoniae (Mhyop) was investigated in two animal studies. In a PRRSV challenge model in pregnant sows (n = 18), six sows received water medicated at target dose of 5 mg tylvalosin/kg body weight/day from 3 days prior to challenge until the end of gestation. Six sows were left untreated, with a third group remaining untreated and unchallenged. Sows were challenged with PRRSV-2 at approximately 85 days of gestation. Cytokines, viremia, viral shedding, sow reproductive parameters and piglet performance to weaning were evaluated. In a dual infection study (n = 16), piglets were challenged with Mhyop on days 0, 1 and 2, and with PRRSV-1 on day 14 and euthanized on day 24. From day 10 to 20, eight piglets received water medicated at target dose of 20 mg tylvalosin/kg body weight/day and eight piglets were left untreated. Cytokines, viremia, bacteriology and lung lesions were evaluated.. Overall, tylvalosin reduced both local and systemic proinflammatory cytokines after challenge with respiratory pathogens in sows and in piglets. Tylvalosin was effective in reducing Mhyop recovery from the lungs and may reduce virus shedding in piglets following transplacental PRRSV infection in sows.

    Topics: Animals; Body Weight; Cytokines; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-10; Interleukin-12; Interleukin-8; Mycoplasma hyopneumoniae; Porcine Reproductive and Respiratory Syndrome; Porcine respiratory and reproductive syndrome virus; Pregnancy; Swine; Swine Diseases; Tumor Necrosis Factor-alpha; Viremia

2023